Table 3. Factors associated with select HHS-defined care indicators, DC Cohort, 2011–2016a,b,c.
| Retention in care | Prescribed ARV therapy | Viral load suppression | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N | Row % | P-value | aOR (95% CI) |
N | Row % | P-value | aOR (95% CI) |
N | Row% | P-value | aOR (95% CI) |
|
| Total | 3,450 | 68.8 | 6,795 | 95.3 | 5,806 | 83.8 | ||||||
| Age | ||||||||||||
| <47 | 1,556 | 64.6 | <0.0001 | Ref | 3,342 | 94.5 | 0.0013 | Ref | 2,740 | 80.0 | <0.0001 | Ref |
| ≥47 | 1,894 | 72.6 | 1.5 (1.3, 1.8) | 3,453 | 96.1 | 1.5 (1.1, 2.1) | 3,066 | 87.7 | 1.8 (1.5, 2.2) | |||
| Sex at birth | ||||||||||||
| Male | 2,510 | 69.0 | 0.4885 | Ref | 4,960 | 95.8 | 0.0013 | Ref | 4,282 | 85.4 | <0.0001 | Ref |
| Female | 940 | 68.0 | 0.9 (0.7, 1.2) | 1,835 | 94.0 | 0.7 (0.4, 1.0) | 1,524 | 79.8 | 0.9 (0.7, 1.1) | |||
| Race | ||||||||||||
| Black | 2,754 | 69.1 | 0.4198 | 1.0 (0.8, 1.3) | 5,298 | 95.2 | 0.5918 | 1.0 (0.6, 1.5) | 4,420 | 81.6 | <0.0001 | 0.4 (0.3, 0.5) |
| White | 481 | 68.1 | Ref | 989 | 95.8 | Ref | 921 | 93.0 | Ref | |||
| Other/ Unknownd |
215 | 65.8 | 0.9 (0.6, 1.4) | 508 | 94.8 | 0.9 (0.4, 1.7) | 465 | 89.4 | 0.7 (0.4, 1.2) | |||
| HIV Riske | ||||||||||||
| MSM | 1,290 | 67.5 | <0.0001 | Ref | 2,641 | 95.4 | 0.0793 | Ref | 2,310 | 86.6 | <0.0001 | Ref |
| HRH | 1,083 | 66.8 | 0.9 (0.7, 1.2) | 2,197 | 94.9 | 1.1 (0.7, 1.7) | 1,862 | 82.2 | 0.9 (0.7, 1.1) | |||
| IDU | 297 | 76.0 | 1.3 (0.9,1.8) | 461 | 93.5 | 0.6 (0.3, 1.1) | 392 | 83.2 | 0.7 (0.5, 1.1) | |||
| Other | 224 | 80.3 | 2.8 (1.8, 4.3) | 337 | 94.9 | 1.2 (0.6, 2.6) | 237 | 68.5 | 0.5 (0.3, 0.7) | |||
| Unknown | 556 | 68.3 | 0.9 (0.7, 1.2) | 1,159 | 96.5 | 1.4 (0.9, 2.4) | 1,005 | 85.6 | 1.0 (0.7, 1.3) | |||
| Clinic Type | ||||||||||||
| Hospital-based | 1,495 | 63.8 | <0.0001 | Ref | 3,190 | 95.3 | 0.8139 | Ref | 2,717 | 82.8 | 0.0203 | Ref |
| Community-based | 1,955 | 73.1 | 1.7 (1.4, 2.0) | 3,605 | 95.2 | 1.0 (0.7, 1.3) | 3,089 | 84.8 | 1.2 (1.0, 1.4) | |||
aRow percent represents the proportion of participants who met the specific measure out of the population in each demographic group.
bP-value represents statistical differences by demographic characteristics; P-values less than 0.0083 are considered statistically significant, using a Bonferroni correction for multiple testing.
cAdjusted odds ratio (aOR) are adjusted for all other variables presented in the table; aORs in bold denote statistical differences at the 0.0083 level, using a Bonferroni correction for multiple testing.
dOther race includes races reported as Hispanic, Asian, American Indian/Native American, Hawaiian/Other Pacific Islander, White-Black, and Other.
eMSM risk includes persons identified as having both MSM and injection drug use risk. Other risk includes perinatal transmission (65%), transfusion/coagulation disorder (19%), hemophiliacs and risk due to occupational exposure and other (16%).
Note. HHS = Health and Human Services; ARV = antiretroviral; OR = odds ratio; CI = confidence interval; MSM = men who have sex with men; HRH = high risk heterosexual risk; IDU = injection drug use; CBO = community-based organization